Cite
HARVARD Citation
Bradley, J. et al. (2020). Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133+ cells in clear cell renal carcinoma. FASEB bioAdvances. 2 (2), pp. 126-144. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bradley, J. et al. (2020). Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133+ cells in clear cell renal carcinoma. FASEB bioAdvances. 2 (2), pp. 126-144. [Online].